All eyes will be on the IVC filter file in a couple of weeks when the first IVC filter recall lawsuits go to trial as bellwether cases in September. While there are various manufacturers faced with pending litigation, Cook Medical is the first manufacturer to go to trial after attempts at settling cases out of court proved unsuccessful.
The inferior vena cava is a primary artery that carries blood up from the lower extremities. While the production of small blood clots in the legs and lower extremities is not normally life-threatening, the situation becomes dire if blood clots find their way to the lungs via the inferior vena cava. The inferior vena cava filter, a spider-like device, was formed as a temporary measure to block the migration of blood clots and entrap the clots within its thin struts, in an attempt to prevent a blood clot from reaching the lungs.You can know more on ivc filter via http://www.bardfilterlawsuitcenter.com/bard-ivc-filter-lawsuit-lawyers.asp.
Various manufacturers came to the table with devices containing Cook Medical and C.R. Bard, makers of the Bard G2 IVC filter. The US Food and Drug Administration (FDA) approved the devices as a temporary answer to stop blood clot migration in patients who could not tolerate blood thinners. However, IVC filters were meant to be retrieved once danger of blood clot migration had passed.
In reality, the majority of retrievable IVC filters are not successfully retrieved. What’s more, struts have been found to break away and migrate along the inferior vena cava, impacting aortic walls or vital organs such as the heart. In some patients, the entire device has detached from its insertion point and migrated to the heart or other vital organs.